Sign in

CIK 0001127537

  • Non-accelerated filer
  • Smaller reporting company

Pulmonx Corp

Sign in to watch
Ticker
LUNG
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-364-0400
Business address
700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Former names
PULMONX
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$177,048
in 4 filings

Net −$177,048. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 8 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-01 Lehman David Aaron General Counsel Sale −679 $18.05 $12K 46,311
2022-06-01 Florin Daniel P Director Grant or award +5,600 13,132
2022-06-01 Lynch Alissa Hsu Director Grant or award +5,600 10,210
2022-05-16 French Glendon E. III President and CEO Gift −25,000 1,107,517
2022-03-10 Rose Geoffrey Beran Chief Commercial Officer Exercise or conversion +29,427 $2.10 $62K 184,129
2022-03-10 Rose Geoffrey Beran Chief Commercial Officer Exercise or conversion · Employee Stock Option (right to buy) −29,427 18,192
2022-03-01 Sung Derrick Chief Financial Officer Sale −458 $25.91 $12K 224,962
2022-03-01 Sung Derrick Chief Financial Officer Grant or award +31,000 255,962
2022-03-01 Sung Derrick Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +68,700 68,700
2022-03-01 Rose Geoffrey Beran Chief Commercial Officer Sale −426 $25.91 $11K 123,702
2022-03-01 Rose Geoffrey Beran Chief Commercial Officer Grant or award +31,000 154,702
2022-03-01 Rose Geoffrey Beran Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +68,700 68,700
2022-03-01 Lehman David Aaron General Counsel Sale −458 $25.91 $12K 16,376
2022-03-01 Lehman David Aaron General Counsel Grant or award +31,000 47,376
2022-03-01 Lehman David Aaron General Counsel Grant or award · Employee Stock Option (right to buy) +68,700 68,700
2022-03-01 French Glendon E. III President and CEO Sale −1,132 $25.91 $29K 1,062,817
2022-03-01 French Glendon E. III President and CEO Grant or award +69,700 1,132,517
2022-03-01 French Glendon E. III President and CEO Grant or award · Employee Stock Option (right to buy) +154,600 154,600
2022-02-18 French Glendon E. III President and CEO Sale −8,561 $26.81 $230K 1,067,888
2022-02-18 French Glendon E. III President and CEO Sale −3,939 $27.13 $107K 1,063,949

Page 16 of 23 · 450 trades